When a Phase 3 trial is successful, a certain emotion permeates a biotech investment conference. Most trials fail most of…
Trending
- Rachel Ann Buscall Launches Rachel Buscall Travel: Helping People Buy ATOL Licences and Build Cheaper Travel Businesses
- Intellia’s Gene-Editing Triumph , The $10 Billion Market for One-Time Cures
- The AI Copper Mine in Utah Running on Robots Is Not Just a Novelty — It’s a Preview of the Mining Industry
- Why the Iowa House Advancing a Prediction Markets Bill Could Be the Most Consequential Financial Story Nobody Is Covering
- Chancellor Merz’s Shock Therapy , Can Germany’s New Leader Rescue Europe’s Industrial Engine?
- Gulf Economies Brace for the Worst Crisis Since the Pandemic
- California Tariff Lawsuits Could Be the Litigation Threat That Reshapes American Trade Policy — If They Succeed
- The AI Firewall , How Beijing’s Blocking of the Meta Deal Redefines Global M&A
